baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

IWG PLC/ JE00BYVQYS01 /

5/14/2024 5:29:33 PM	Chg. -0.80	Volume	Bid5:30:00 PM	Ask5:30:00 PM	High	Low
199.60GBX	-0.40%	260,313 Turnover(GBP): 521,241.9895	-Bid Size: -	-Ask Size: -	201.00	198.70

GlobeNewswire 3/26 argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thr...

GlobeNewswire 12/11/2023 Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of H...

GlobeNewswire 11/28/2023 argenx Reports Topline Results from ADVANCE-SC Study of VYVGART Hytrulo in Primary Immune Thrombocyt...

Newsfile Corp 10/5/2023 GoGlobal Announces Partnership with IWG to Offer Office Space and Hybrid Working Solutions to Client...

GlobeNewswire 2/24/2022 Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results

GlobeNewswire 12/13/2021 Corrected: Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050...

GlobeNewswire 12/13/2021 Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program an...

GlobeNewswire 11/12/2021 Biosight Announces Initiation of Phase 2 Clinical Trial of Aspacytarabine for MDS and AML

GlobeNewswire 8/9/2021 HUTCHMED and Epizyme Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazeme...

GlobeNewswire 7/29/2021 Teleflex Reports Second Quarter 2021 Results and Full Year Outlook

GlobeNewswire 5/13/2021 Carbon180 Unveils Carbon Removal Policy Roadmap for 2021 and Beyond

GlobeNewswire 4/29/2021 Teleflex Reports First Quarter 2021 Results

GlobeNewswire 2/25/2021 Teleflex Reports Fourth Quarter and Full Year 2020 Results; Provides 2021 Guidance

GlobeNewswire 12/28/2020 Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in TP53 ...

GlobeNewswire 12/6/2020 MacroGenics Presents Flotetuzumab Data in Patients with Refractory Acute Myeloid Leukemia at the 202...

GlobeNewswire 10/29/2020 Teleflex Reports Third Quarter 2020 Results

GlobeNewswire 7/30/2020 Teleflex Reports Second Quarter 2020 Results

GlobeNewswire 6/12/2020 Aprea Therapeutics Presents Results From French Phase Ib/II Clinical Trial of APR-246 (Eprenetapopt)...

GlobeNewswire 4/30/2020 Teleflex Reports First Quarter 2020 Results

GlobeNewswire 4/27/2020 MacroGenics Announces Presentation of Flotetuzumab Translational Data at the 2020 AACR Annual Meetin...

GlobeNewswire 2/20/2020 Teleflex Reports Fourth Quarter and Full Year 2019 Results; Provides 2020 Guidance

GlobeNewswire 12/12/2019 Recap and Update of Positive Data from Phase Ib/II Clinical Trials of APR-246 and Azacitidine (AZA) ...

GlobeNewswire 12/10/2019 Stemline Therapeutics Recaps ELZONRIS Clinical Data Presentations in Patients with Myelofibrosis (or...

GlobeNewswire 12/9/2019 MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed...

GlobeNewswire 12/9/2019 Aprea Therapeutics Presents Results From U.S. Phase Ib/II Clinical Trial of APR-246 and Azacitidine ...

IWG PLC/ JE00BYVQYS01 /

If you wish to receive reply to your feedback, please provide your email address.